Half-year report · Q2
4548.TEDINET S100UQ49
Period2024-04-01 → 2024-09-30
Filed2024-11-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥20.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥36.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥2.5bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥1.5bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥2.4bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.7bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.3bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.4bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.3bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.9bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.9bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥2.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥84.4bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥81.8bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥79.6bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥9.1bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥9.5bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥75.3bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥72.3bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥71.5bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥16.9bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.4bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥19.8bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.0bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥25.8bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥3.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥513m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥490m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.6bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥732m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥731m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥35.39 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40.08 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.54 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 89.2% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.4% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E00970-000LALreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥5.9bn |
| jpcrp040300-q2r_E00970-000LALreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥5.9bn |
| jpcrp040300-q2r_E00970-000LALreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥481m |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥14.3bn |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥14.3bn |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2.1bn |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥20.2bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥20.2bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥2.5bn |
| jpcrp040300-q2r_E00970-000LALreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥5.0bn |
| jpcrp040300-q2r_E00970-000LALreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥5.0bn |
| jpcrp040300-q2r_E00970-000LALreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥420m |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥13.1bn |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥13.1bn |
| jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.1bn |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥18.1bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥18.1bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥1.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 518
| Item | Context | Value | Unit |
|---|---|---|---|
| Foreign currency translation adjustment | Prior1YearInstant | 4180000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 6261000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 954000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 878000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 10661000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 12432000000 | JPY |
| Net assets | Prior1YearInstant | 72282000000 | JPY |
| Net assets | CurrentQuarterInstant | 75289000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 81795000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 84360000000 | JPY |
| Net sales | Prior1YTDDuration | 18061000000 | JPY |
| Net sales | CurrentYTDDuration | 20210000000 | JPY |
| Cost of sales | Prior1YTDDuration | 8869000000 | JPY |
| Cost of sales | CurrentYTDDuration | 9488000000 | JPY |
| Gross profit | Prior1YTDDuration | 9192000000 | JPY |
| Gross profit | CurrentYTDDuration | 10721000000 | JPY |
| Personal expenses sga | Prior1YTDDuration | 1543000000 | JPY |
| Personal expenses sga | CurrentYTDDuration | 1760000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 182000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 201000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 50000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 48000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 3410000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 3243000000 | JPY |
| Other sga | Prior1YTDDuration | 2523000000 | JPY |
| Other sga | CurrentYTDDuration | 2930000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 7709000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 8184000000 | JPY |
| Operating income | Prior1YTDDuration | 1482000000 | JPY |
| Operating income | CurrentYTDDuration | 2537000000 | JPY |
| Interest income noi | Prior1YTDDuration | 66000000 | JPY |
| Interest income noi | CurrentYTDDuration | 86000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 200000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 217000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 582000000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | - | JPY |
| Other noi | Prior1YTDDuration | 30000000 | JPY |
| Other noi | CurrentYTDDuration | 28000000 | JPY |
| Non operating income | Prior1YTDDuration | 880000000 | JPY |
| Non operating income | CurrentYTDDuration | 332000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 2000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 2000000 | JPY |
| Foreign exchange losses noe | Prior1YTDDuration | - | JPY |
| Foreign exchange losses noe | CurrentYTDDuration | 499000000 | JPY |
| Commission fee noe | Prior1YTDDuration | 2000000 | JPY |
| Commission fee noe | CurrentYTDDuration | 2000000 | JPY |
| Business structure improvement expenses noe | Prior1YTDDuration | 29000000 | JPY |
| Business structure improvement expenses noe | CurrentYTDDuration | - | JPY |
| Other noe | Prior1YTDDuration | 1000000 | JPY |
| Other noe | CurrentYTDDuration | 12000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |